Intraosseous infusion
Closed Solicitation Posted
- Solicitation number
- SPE2DS27T1048
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- Not on record
- More information
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical Supply Chain, through its SPE2DS contracting office, sought quotations under RFQ SPE2DS27T1048 for one box of intraosseous infusion kits (NSN 6515-01-647-1590), with quotes due November 3, 2026. The Set Aside line reads No Set-Aside Used, and the RFQ is a Fast Auto Evaluation solicitation issued through DIBBS, which is the required submission channel.
The item is delivered FOB Destination with inspection and acceptance at destination, and delivery is due within 20 days to USS Idaho (SSN 799) by vessel shipment. Per the attached RFQ summary, the kits are EZ-IO 25MM units from Teleflex LLC (CAGE 8BXN8, Part Number 9001P-VC-005), each box containing 5 units with needle sets, stabilizer dressing, extension sets, sharps blocks, and patient wristbands. The item must have a 48-month shelf life and no more than 7 months elapsed from manufacture to delivery. It is FDA-regulated as a Class II device requiring 510(k) clearance.
The RFQ incorporates the DLA Master Solicitation for Automated Simplified Acquisitions and DLA Master List technical and quality requirements. Compliance provisions include the Buy American Act, the Berry Amendment with a reduced threshold of $150,000, hazard warning labels, safeguarding of covered defense information, U.S.-flag vessel transport, small business program representations, and a covered telecommunications representation. Payment processes through Wide Area WorkFlow (WAWF).
Pricing history shows prior awards to vendors 1KA59, 0AG09, and 1WAS9 at unit costs of approximately $698 to $785 between May and June 2026. The procurement note states this buy may be a candidate for automated award if no first article test requirements apply. The source does not state evaluation criteria.
Notice text
DLA request for quotation SPE2DS27T1048, issued by DLA office SPE2DS through DIBBS. Quotes are due by 11/03/2026. Set-aside: No Set-Aside Used. Solicitation type: Fast Auto Evaluation. FOB Destination. Inspection at Destination. Item: line 0001, INTRAOSSEOUS INFUSION, NSN 6515-01-647-1590, 1 BX, delivery in 20 days, PR 7018885304. Quotes must be submitted via DIBBS.
Files
| File | Type | Posted |
|---|---|---|
| SPE2DS27T1048.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Injector,intraosseous | Medical Supply Chain | No set-aside | |
| Intraosseous infusion | Medical Supply Chain | No set-aside | |
| Needle set,intraosseo | Medical Supply Chain | No set-aside | |
| Needle set,intraosseo | Medical Supply Chain | No set-aside | |
| Insert,medical instru | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity